0 NASDAQ Companies - February 26, 2024Gevo Hires Damien Perriman as Chief Business Development OfficerENGLEWOOD, Colo., Feb. 26, 2024 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) is pleased to announce that Damien Perriman has […]Read More
0 NASDAQ Companies - February 26, 2024Rail Vision Sets New Safety Standards for Europe: Achieves Regulatory Approval and Certificate for Railway Operation in the EURa’anana, Israel, Feb. 26, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the […]Read More
0 NASDAQ Companies - February 26, 2024Global Water Resources to Present at the 36th Annual ROTH Conference, March 17-19, 2024PHOENIX, Feb. 26, 2024 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has […]Read More
0 NASDAQ Companies - February 26, 2024Ocugen Chairman and CEO to present at Abu Dhabi Family Office SummitMALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused […]Read More
0 NASDAQ Companies - February 26, 2024Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health […]Read More
0 NASDAQ Companies - February 26, 2024Lantheus to Present at the TD Cowen 44th Annual Health Care ConferenceBEDFORD, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to […]Read More
0 NASDAQ Companies - February 26, 2024Trust Stamp Announces the Continued Growth of its Patent Portfolio Encompassing AI-Powered Identity SolutionsAtlanta, Georgia, Feb. 26, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM announced that on January […]Read More
0 NASDAQ Companies - February 26, 2024Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care ConferenceBOSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical […]Read More
0 NASDAQ Companies - February 26, 2024Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the […]Read More
0 NASDAQ Companies - February 26, 2024LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCIAgreement Focuses on Combining LIXTE’s LB-100 with Various Innovative Cancer Immunotherapies PASADENA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) — LIXTE […]Read More